Table 2: Comparison of blood glucose and pancreatic islet function among study groups.

VariableSPK ()RT ()CRF ()CON ()

Blood glucose (mmol/L), median (IQR)5.0 (5.6-5.2)6.1 (5.4–7.3)##7.7 (6.9, 8.8)##4.0 (3.8-4.3)##<0.001
Glycosylated hemoglobin (%), median (IQR)4.8 (4.2-5.2)7.3 (6.7–8.3)##7.5 (6.7–8.8)##4.2 (4.0-5.0)<0.001
Insulin (μIU/mL), median (IQR)6.8 (5.8–8.3)4.8 (4.0-5.3)##5.3 (3.6–6.4)##7.7 (6.0–8.8)<0.001
C-peptide (ng/mL), median (IQR)4.2 (3.6–6.5)3.4 (2.9-3.5)##3.4 (2.5–4.0)##4.7 (4.3-5.7)<0.001
FPE (μg/g), median (IQR)479 (335–557)197 (185–502)#229 (163–457)##441 (341–554)0.003
 <200 μg/g (%)1 (5.3)12 (54.5)14 (45.2)1 (5.0)<0.001
 ≧200 μg/g (%)18 (94.7)20 (45.5)17 (54.8)19 (95.0)‚ÄČ

Comparison among four groups; #compared with the SPK group, ; ##compared with the SPK group, . SPK: simultaneous pancreas–kidney transplantation; CRF: diabetic patients with uremia (chronic renal failure); RT: diabetic patients with uremia who underwent renal transplantation; CON: normal individuals; FPE: fecal pancreatic elastase.